These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
513 related articles for article (PubMed ID: 7908989)
1. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines. Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989 [TBL] [Abstract][Full Text] [Related]
2. Modulation of doxorubicin sensitivity by cyclosporine A in hepatocellular carcinoma cells and their doxorubicin-resistant sublines. Shiraga K; Sakaguchi K; Senoh T; Ohta T; Ogawa S; Sawayama T; Mouri H; Fujiwara A; Tsuji T J Gastroenterol Hepatol; 2001 Apr; 16(4):460-6. PubMed ID: 11354286 [TBL] [Abstract][Full Text] [Related]
3. Human hepatocellular carcinoma cell lines exhibit multidrug resistance unrelated to MRD1 gene expression. Shen DW; Lu YG; Chin KV; Pastan I; Gottesman MM J Cell Sci; 1991 Mar; 98 ( Pt 3)():317-22. PubMed ID: 1676033 [TBL] [Abstract][Full Text] [Related]
4. Chemosensitivity patterns and expression of human multidrug resistance-associated MDR1 gene by human gastric and colorectal carcinoma cell lines. Park JG; Kramer BS; Lai SL; Goldstein LJ; Gazdar AF J Natl Cancer Inst; 1990 Feb; 82(3):193-8. PubMed ID: 1967320 [TBL] [Abstract][Full Text] [Related]
5. Constitutive expression of functional P-glycoprotein in rat hepatoma cells. Fardel O; Loyer P; Lecureur V; Glaise D; Guillouzo A Eur J Biochem; 1994 Jan; 219(1-2):521-8. PubMed ID: 7905826 [TBL] [Abstract][Full Text] [Related]
6. Combined use of tamoxifen, cyclosporin A, and verapamil for modulating multidrug resistance in human hepatocellular carcinoma cell lines. Kim JH; Chung JB; Park IS; Kim BS; Yoo NC; Choi JH; Roh JK; Kim HS; Kwon OH; Lee KS Yonsei Med J; 1993 Mar; 34(1):35-44. PubMed ID: 8397460 [TBL] [Abstract][Full Text] [Related]
7. Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. Stein U; Walther W; Shoemaker RH J Natl Cancer Inst; 1996 Oct; 88(19):1383-92. PubMed ID: 8827016 [TBL] [Abstract][Full Text] [Related]
8. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdr1 gene activation by the cyclosporin PSC 833. Beketic-Oreskovic L; DurĂ¡n GE; Chen KG; Dumontet C; Sikic BI J Natl Cancer Inst; 1995 Nov; 87(21):1593-602. PubMed ID: 7563202 [TBL] [Abstract][Full Text] [Related]
9. New potent verapamil derivatives that reverse multidrug resistance in human renal carcinoma cells and in transgenic mice expressing the human MDR1 gene. Mickisch GH; Merlino GT; Aiken PM; Gottesman MM; Pastan I J Urol; 1991 Aug; 146(2):447-53. PubMed ID: 1677434 [TBL] [Abstract][Full Text] [Related]
10. Chemosensitisation of spontaneous multidrug resistance by a 1,4-dihydropyridine analogue and verapamil in human glioma cell lines overexpressing MRP or MDR1. Abe T; Koike K; Ohga T; Kubo T; Wada M; Kohno K; Mori T; Hidaka K; Kuwano M Br J Cancer; 1995 Aug; 72(2):418-23. PubMed ID: 7640227 [TBL] [Abstract][Full Text] [Related]
11. Response of small-cell lung cancer xenografts to chemotherapy: multidrug resistance and direct clinical correlates. Poupon MF; Arvelo F; Goguel AF; Bourgeois Y; Jacrot M; Hanania N; Arriagada R; Le Chevalier T J Natl Cancer Inst; 1993 Dec; 85(24):2023-9. PubMed ID: 7902445 [TBL] [Abstract][Full Text] [Related]
12. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. Chaudhary PM; Roninson IB J Natl Cancer Inst; 1993 Apr; 85(8):632-9. PubMed ID: 8096875 [TBL] [Abstract][Full Text] [Related]
13. P-glycoprotein expression in hepatocellular carcinoma. Isshiki K; Nakao A; Ito M; Hamaguchi M; Takagi H J Surg Oncol; 1993 Jan; 52(1):21-5. PubMed ID: 8095077 [TBL] [Abstract][Full Text] [Related]
14. MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants. Kanamaru H; Kakehi Y; Yoshida O; Nakanishi S; Pastan I; Gottesman MM J Natl Cancer Inst; 1989 Jun; 81(11):844-9. PubMed ID: 2724349 [TBL] [Abstract][Full Text] [Related]
15. Differential over-expression of mdr1 genes in multidrug-resistant rat glioblastoma cell lines selected with doxorubicin or vincristine. Schott B; Bennis S; Pourquier P; Ries C; Londos-Gagliardi D; Robert J Int J Cancer; 1993 Aug; 55(1):115-21. PubMed ID: 8102127 [TBL] [Abstract][Full Text] [Related]
16. Multidrug resistance in cultured human leukemia and lymphoma cell lines detected by a monoclonal antibody, MRK16. Ishida Y; Ohtsu T; Hamada H; Sugimoto Y; Tobinai K; Minato K; Tsuruo T; Shimoyama M Jpn J Cancer Res; 1989 Oct; 80(10):1006-13. PubMed ID: 2575608 [TBL] [Abstract][Full Text] [Related]
17. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line. Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823 [TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Noonan KE; Beck C; Holzmayer TA; Chin JE; Wunder JS; Andrulis IL; Gazdar AF; Willman CL; Griffith B; Von Hoff DD; Roninson IB Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7160-4. PubMed ID: 1976252 [TBL] [Abstract][Full Text] [Related]
19. Cyclosporin A, verapamil and S9788 reverse doxorubicin resistance in a human medullary thyroid carcinoma cell line. Massart C; Gibassier J; Raoul M; Pourquier P; Leclech G; Robert J; Lucas C Anticancer Drugs; 1995 Feb; 6(1):135-46. PubMed ID: 7756676 [TBL] [Abstract][Full Text] [Related]
20. The study of innate drug resistance of human hepatocellular carcinoma Bel7402 cell line. Huang M; Liu G Cancer Lett; 1999 Jan; 135(1):97-105. PubMed ID: 10077227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]